HealthcareFDA Warning Letter to Kestra Rival Puts Global Wearable Defibrillator Market on NoticeSalvado•Jul 17, 2026
Mergers & AcquisitionsEaton's $3.5 Billion Boyd Thermal Deal Faces Multi-Jurisdiction Antitrust ReviewViaNews Editorial Team•Mar 4, 2026
Corporate FinanceKřetínský's €1.6bn Fnac Darty Bid Faces 70% Rejection Risk as EU Tightens Foreign Retail ControlViaNews Editorial Team•Mar 1, 2026
Corporate LitigationImperial Brands faces 70% litigation risk across three continents as tobacco lawsuits intensifyViaNews Editorial Team•Feb 28, 2026
biotechnologyCannabis Biotech Bets Everything on Single Intoxication Drug as Global THC Products Hit 90% PotencyViaNews Editorial Team•Feb 23, 2026
HealthcareExeltis Tafoxiparin Deal Faces 45-60% Regulatory Failure Rate Across Global MarketsViaNews Editorial Team•Feb 21, 2026
